Guhan Pharmaceutical Group Co., Ltd. (SHE:000590)
China flag China · Delayed Price · Currency is CNY
9.27
-0.19 (-2.01%)
Sep 10, 2026, 3:04 PM CST

SHE:000590 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
106.13177.71177.29189.77235.42250.68
Trading Asset Securities
35---25.1175.15
Cash & Short-Term Investments
141.13177.71177.29189.77260.53325.83
Cash Growth
-34.83%0.24%-6.58%-27.16%-20.04%-4.99%
Accounts Receivable
64.8768.94103.15154.4117.16124.81
Other Receivables
16.8516.1490.2860.5130.116
Receivables
81.7385.08193.43214.91147.27130.82
Inventory
121.69109.57124.78130.09118.2286.59
Prepaid Expenses
-0.522.32-0.030
Other Current Assets
13.665.982.174.793.0610.65
Total Current Assets
358.21378.87499.99539.55529.11553.88
Property, Plant & Equipment
311.58308.31312.66293.81289.75240.89
Long-Term Investments
23.4523.0220.0320.91919
Goodwill
--13.2131.64137.14-
Other Intangible Assets
120.93123.45131.06132.33157.44133.69
Long-Term Accounts Receivable
-2.033.095.057.42-
Long-Term Deferred Tax Assets
15.2214.98.184.095.234.97
Long-Term Deferred Charges
6.037.46.293.322.931.82
Other Long-Term Assets
30.7331.4918.9220.421913.57
Total Assets
866.14889.471,0131,1511,167967.83

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Accounts Payable
93.7764.0773.2483.5564.0141.67
Accrued Expenses
19.7238.9743.8846.6250.840.37
Short-Term Debt
--0.75-25.82-
Current Portion of Long-Term Debt
10.6820.0611.011010.1-
Current Portion of Leases
-1.12.942.362.693
Current Income Taxes Payable
2.50.036.82.33.43.85
Current Unearned Revenue
20.8936.1545.3350.1256.1353.42
Other Current Liabilities
39.3840.9552.3153.8258.4544.68
Total Current Liabilities
186.93201.33236.26248.77271.42186.98
Long-Term Debt
58.345082.228090-
Long-Term Leases
0.270.811.493.075.185.59
Long-Term Unearned Revenue
43.7844.9843.9942.4444.3746.29
Long-Term Deferred Tax Liabilities
5.35.815.155.917.470.02
Other Long-Term Liabilities
37.7637.0543.0742.7246.0946.62
Total Liabilities
332.38339.98412.18422.92464.53285.5

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Common Stock
239.47239.47239.47239.47239.47239.47
Additional Paid-In Capital
473.95473.95474.06474.06474.06474.06
Retained Earnings
-180.78-165.81-115.2910.18-15.06-33.21
Total Common Equity
532.64547.61598.25723.72698.47680.32
Minority Interest
1.121.872.994.494.032
Shareholders' Equity
533.76549.49601.23728.2702.5682.32
Total Liabilities & Equity
866.14889.471,0131,1511,167967.83

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Total Debt
69.2871.9798.4295.43133.798.58
Net Cash (Debt)
71.84105.7478.8794.34126.74317.24
Net Cash Growth
-12.83%34.07%-16.40%-25.56%-60.05%-6.13%
Net Cash Per Share
0.300.440.330.390.531.32
Filing Date Shares Outstanding
239.94239.47239.47239.47239.47239.47
Total Common Shares Outstanding
239.94239.47239.47239.47239.47239.47
Working Capital
171.28177.54263.73290.78257.69366.9
Book Value Per Share
2.222.292.503.022.922.84
Tangible Book Value
411.72424.17453.98459.75403.89546.63
Tangible Book Value Per Share
1.721.771.901.921.692.28
Buildings
-253.52267.95247.28243.93198.81
Machinery
-228.54220.21197.31189.09174.95
Construction In Progress
-23.098.8123.8315.214.18